GB1519495A - Azetidinone derivatives and process for preparation thereof - Google Patents

Azetidinone derivatives and process for preparation thereof

Info

Publication number
GB1519495A
GB1519495A GB28394/75A GB2839475A GB1519495A GB 1519495 A GB1519495 A GB 1519495A GB 28394/75 A GB28394/75 A GB 28394/75A GB 2839475 A GB2839475 A GB 2839475A GB 1519495 A GB1519495 A GB 1519495A
Authority
GB
United Kingdom
Prior art keywords
preparation
azetidinone derivatives
azetidinone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB28394/75A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP49077091A external-priority patent/JPS51125061A/en
Priority claimed from JP49085526A external-priority patent/JPS51125062A/en
Priority claimed from JP49088452A external-priority patent/JPS51125064A/en
Priority claimed from JP50002650A external-priority patent/JPS5175056A/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of GB1519495A publication Critical patent/GB1519495A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
GB28394/75A 1974-07-04 1975-07-04 Azetidinone derivatives and process for preparation thereof Expired GB1519495A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP49077091A JPS51125061A (en) 1974-07-04 1974-07-04 A process for 3-acylaminoazetidinone derivatives
JP49085526A JPS51125062A (en) 1974-07-24 1974-07-24 A process for preparing 3-aminoazetidinone
JP49088452A JPS51125064A (en) 1974-07-31 1974-07-31 A process for preparing 1-substituted-3- acylaminoazetidinone derivati ves
JP50002650A JPS5175056A (en) 1974-12-23 1974-12-23 33 chikanazejinonjudotaino seizoho

Publications (1)

Publication Number Publication Date
GB1519495A true GB1519495A (en) 1978-07-26

Family

ID=27453685

Family Applications (1)

Application Number Title Priority Date Filing Date
GB28394/75A Expired GB1519495A (en) 1974-07-04 1975-07-04 Azetidinone derivatives and process for preparation thereof

Country Status (4)

Country Link
DE (1) DE2529941A1 (en)
FR (1) FR2278335A1 (en)
GB (1) GB1519495A (en)
NZ (1) NZ178019A (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US4416817A (en) 1979-06-08 1983-11-22 Takeda Chemical Industries, Ltd. 3-Methoxy-2-oxoazetidine derivatives and their production
US4427581A (en) 1981-01-29 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US6509331B1 (en) 1998-06-22 2003-01-21 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6528505B1 (en) 1998-06-22 2003-03-04 Elan Pharmaceuticals, Inc. Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6541466B2 (en) 1996-12-23 2003-04-01 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6774125B2 (en) 1998-06-22 2004-08-10 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6838455B2 (en) 1998-06-22 2005-01-04 Athena Neurosciences, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
EP1911738A1 (en) * 2005-07-29 2008-04-16 Takeda Pharmaceutical Company Limited Phenoxyalkanoic acid compound
WO2007065288A3 (en) * 2005-12-07 2008-06-05 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
CN115925585A (en) * 2022-04-22 2023-04-07 广州医科大学 Chlorofol derivative, antibacterial drug, preparation method and application

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207234A (en) * 1975-07-07 1980-06-10 Fujisawa Pharmaceutical Co., Ltd. 4-Unsubstituted azetidinone derivatives and process for preparation thereof
JPS5261291A (en) * 1975-11-14 1977-05-20 Fujisawa Pharmaceut Co Ltd Preparation of fr-29611 substance and/or fr-29612 substance
NL7806860A (en) * 1977-07-05 1979-01-09 Farmaceutici Italia PROCESS FOR PREPARING NOCARDICIN-RELATED AZETIDINONES.
US4195021A (en) 1977-10-26 1980-03-25 Eli Lilly And Company 1,3-Disubstituted 2-azetidinone antibitotics
EP0005507A1 (en) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Process for the fragmentation of 3-(2-hydroxyimino-acetylamino)-2-oxo azetidin compounds and compounds obtained thereby
CA1338538C (en) * 1979-06-08 1996-08-20 Taisuke Matsuo 1-sulfo-2-oxoazetidine derivatives and their production
GB2173791B (en) * 1985-04-16 1989-07-05 Ici Plc Fungicidal cyano oximes
IL129820A0 (en) * 1996-12-23 2000-02-29 Elan Pharm Inc Cycloalkyl lactam lactone and related compounds as beta-amyloid peptide release inhibitors

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416817A (en) 1979-06-08 1983-11-22 Takeda Chemical Industries, Ltd. 3-Methoxy-2-oxoazetidine derivatives and their production
US4337197A (en) 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US4427581A (en) 1981-01-29 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6951854B1 (en) 1996-12-23 2005-10-04 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6541466B2 (en) 1996-12-23 2003-04-01 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6544978B2 (en) 1996-12-23 2003-04-08 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6559141B2 (en) 1996-12-23 2003-05-06 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US7153847B2 (en) 1996-12-23 2006-12-26 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6579867B2 (en) 1996-12-23 2003-06-17 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6632811B2 (en) 1996-12-23 2003-10-14 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6653303B1 (en) 1996-12-23 2003-11-25 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6667305B1 (en) 1996-12-23 2003-12-23 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6774125B2 (en) 1998-06-22 2004-08-10 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6528505B1 (en) 1998-06-22 2003-03-04 Elan Pharmaceuticals, Inc. Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6838455B2 (en) 1998-06-22 2005-01-04 Athena Neurosciences, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
US6906056B2 (en) 1998-06-22 2005-06-14 Elan Pharmaceuticals, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6509331B1 (en) 1998-06-22 2003-01-21 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
US6696438B2 (en) 1998-06-22 2004-02-24 Elan Pharmaceuticals, Inc. Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
EP1911738A1 (en) * 2005-07-29 2008-04-16 Takeda Pharmaceutical Company Limited Phenoxyalkanoic acid compound
EP1911738A4 (en) * 2005-07-29 2009-12-16 Takeda Pharmaceutical Phenoxyalkanoic acid compound
WO2007065288A3 (en) * 2005-12-07 2008-06-05 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
US8901293B2 (en) 2005-12-07 2014-12-02 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
CN115925585A (en) * 2022-04-22 2023-04-07 广州医科大学 Chlorofol derivative, antibacterial drug, preparation method and application
CN115925585B (en) * 2022-04-22 2023-11-03 广州医科大学 Chlorofacol derivative, antibacterial drug, preparation method and application

Also Published As

Publication number Publication date
FR2278335B1 (en) 1982-12-17
FR2278335A1 (en) 1976-02-13
DE2529941A1 (en) 1976-04-08
NZ178019A (en) 1978-04-28

Similar Documents

Publication Publication Date Title
HU173108B (en) Process for preparing new isoindolinyl-, pyrrolopyrazinyl-, oxathiinopyrrolyl-, and dithiinopyrrolyl-oxy-carbonyl-piperazine derivatives
GB1519495A (en) Azetidinone derivatives and process for preparation thereof
HU171420B (en) Process for preparing derivatives of the sulphonamide-pyridine and pyridine-thiadiazine
ZA75452B (en) Benzylamine derivatives and process for preparing them
JPS51115446A (en) Ppbenzoquinone diketals and process for manufacture thereof
GB1533991A (en) Diacylnucleosides and process for preparing the same
PH12798A (en) 8-hydroxyamino benzazocines and process
ZA756481B (en) 4-methylthio-2-trifluoromethyl methane-sulfonanilide and derivatives thereof
IL47339A (en) Macromolecular adenne derivatives and process for their preparation
YU40114B (en) Process for obtaining polysaccharides and derivatives thereof
IL48276A (en) 7-hydroxy-estradiols and process for their preparation
GB1486493A (en) Cephalosporin derivatives and process for preparing same
GB1516509A (en) Omikron-phenylenediamine derivatives and process for their preparation
IL48320A0 (en) Penicillins and processes for their preparation
GB1519050A (en) Indolo-quinolizine derivatives and a process for the preparation thereof
IL48043A0 (en) Omega-nor-cycloalkyl-13,14-dehydroprostaglandins and process for their preparation
AU8208175A (en) Hexahydro-diazepino-indole derivatives and a process for their preparation
ZA756705B (en) Penicillins and processes for their preparation
YU63274A (en) Process for obtining 3-cephem-3-sulfonate derivatives
IL48065A0 (en) Pgfbeta-prostaglandins and process for their preparation
YU52675A (en) Process for obraining dibenzocycloheptapyrrol derivatives
ZA755816B (en) Thiamindisulphide-orotate and process for its preparation
ZA754306B (en) Azeridinone derivatives and process for preparation thereof
ZA756355B (en) 3,7-dimethyl-3-hydroxy-6-octenenitrile and process for its preparation
CH614216A5 (en) Process for the preparation of deoxyparomomycin and dideoxyparomomycin

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee